Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance-Multicenter, Placebo Controlled, Randomized, Double Blind, Parallel Group Controlled Trial in Patients With Statin Intolerant Hypercholesterolemia-

NCT05923281 is registered in ClinicalTrials.gov with Kowa Company, Ltd. as lead sponsor.

NCT NCT05923281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05923281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance-Multicenter, Placebo Controlled, Randomized, Double Blind, Parallel Group Controlled Trial in Patients With Statin Intolerant Hypercholesterolemia-
Lead sponsor
Kowa Company, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2023
Completion date
August 7, 2024
Enrollment
71 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia